Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
about
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Irinotecan in patients with re ...... Testicular Cancer Study Group.
@en
Irinotecan in patients with re ...... Testicular Cancer Study Group.
@nl
type
label
Irinotecan in patients with re ...... Testicular Cancer Study Group.
@en
Irinotecan in patients with re ...... Testicular Cancer Study Group.
@nl
prefLabel
Irinotecan in patients with re ...... Testicular Cancer Study Group.
@en
Irinotecan in patients with re ...... Testicular Cancer Study Group.
@nl
P2093
P2860
P356
P1476
Irinotecan in patients with re ...... Testicular Cancer Study Group.
@en
P2093
P2860
P2888
P304
1140-1; author reply 1141-2
P356
10.1038/SJ.BJC.6601176
P407
P577
2003-09-01T00:00:00Z
P5875
P6179
1019827331